607 related articles for article (PubMed ID: 17132338)
1. Pandemic influenza: overview of vaccines and antiviral drugs.
Cox MM
Yale J Biol Med; 2005 Oct; 78(5):321-8. PubMed ID: 17132338
[TBL] [Abstract][Full Text] [Related]
2. Vaccines in development against avian influenza.
Cox MM
Minerva Med; 2007 Apr; 98(2):145-53. PubMed ID: 17519856
[TBL] [Abstract][Full Text] [Related]
3. Achieving clinical equality in an influenza pandemic: patent realities.
Kane EM
Seton Hall Law Rev; 2009; 39(4):1137-72. PubMed ID: 20718133
[TBL] [Abstract][Full Text] [Related]
4. Use of neuraminidase inhibitors to combat pandemic influenza.
Democratis J; Pareek M; Stephenson I
J Antimicrob Chemother; 2006 Nov; 58(5):911-5. PubMed ID: 16956904
[TBL] [Abstract][Full Text] [Related]
5. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
Collin N; de Radiguès X;
Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
[TBL] [Abstract][Full Text] [Related]
6. Influenza a (H1N1) outbreak and challenges for pharmacotherapy.
Chawla R; Sharma RK; Bhardwaj JR
Indian J Physiol Pharmacol; 2009; 53(2):113-26. PubMed ID: 20112815
[TBL] [Abstract][Full Text] [Related]
7. Current research on drugs and vaccines for fighting bird flu.
Wiwanitkit V
Trans R Soc Trop Med Hyg; 2007 Dec; 101(12):1171-2. PubMed ID: 17655895
[TBL] [Abstract][Full Text] [Related]
8. Preventing avian influenza in humans: the role of simple public health interventions.
Bhatia R; Narain JP
Southeast Asian J Trop Med Public Health; 2006 Nov; 37(6):1229-36. PubMed ID: 17333782
[TBL] [Abstract][Full Text] [Related]
9. [Influenza vaccine: globalization of public health stakes].
Collin N; Briand S
Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377
[TBL] [Abstract][Full Text] [Related]
10. [The use of antiviral agents during an (impending) influenza pandemic].
Opstelten W; van Steenbergen JE; van Essen GA; Van der Sande MA
Ned Tijdschr Geneeskd; 2007 May; 151(18):1008-12. PubMed ID: 17508684
[TBL] [Abstract][Full Text] [Related]
11. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
[TBL] [Abstract][Full Text] [Related]
12. Conceptional considerations for a German influenza pandemic preparedness plan.
Fock R; Bergmann H; Bussmann H; Fell G; Finke EJ; Koch U; Niedrig M; Peters M; Scholz D; Wirtz A
Med Microbiol Immunol; 2002 Dec; 191(3-4):191-5. PubMed ID: 12458359
[TBL] [Abstract][Full Text] [Related]
13. Pandemics, avian influenza A (H5N1), and a strategy for pharmacists.
Ford SM; Grabenstein JD
Pharmacotherapy; 2006 Mar; 26(3):312-22. PubMed ID: 16503711
[TBL] [Abstract][Full Text] [Related]
14. The risk of seasonal and pandemic influenza: prospects for control.
Monto AS
Clin Infect Dis; 2009 Jan; 48 Suppl 1():S20-5. PubMed ID: 19067611
[TBL] [Abstract][Full Text] [Related]
15. The threat and prospects for control of an influenza pandemic.
Stiver HG
Expert Rev Vaccines; 2004 Feb; 3(1):35-42. PubMed ID: 14761242
[TBL] [Abstract][Full Text] [Related]
16. NEW technologies for meeting the global demand for pandemic influenza vaccines.
Fedson DS
Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803
[TBL] [Abstract][Full Text] [Related]
17. Vaccines and antiviral drugs in pandemic preparedness.
Monto AS
Emerg Infect Dis; 2006 Jan; 12(1):55-60. PubMed ID: 16494718
[TBL] [Abstract][Full Text] [Related]
18. Seasonal and pandemic influenza preparedness: science and countermeasures.
Fauci AS
J Infect Dis; 2006 Nov; 194 Suppl 2():S73-6. PubMed ID: 17163392
[TBL] [Abstract][Full Text] [Related]
19. Seasonal and pandemic influenza: a 2007 update on challenges and solutions.
Monto AS; Whitley RJ
Clin Infect Dis; 2008 Apr; 46(7):1024-31. PubMed ID: 18444819
[TBL] [Abstract][Full Text] [Related]
20. [Pandemic influenza vaccines: from the lab to ethical policy making].
Grotto I; Levine H; Balicer RD
Harefuah; 2009 Oct; 148(10):672-6, 735. PubMed ID: 20073393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
